Modafinil drug is considered as a eurogeroic or a wakefulness-promoting agent. It was designed in France around 1970s, and licensed under Cephalon, a US company in the 1990s. The drug was used to treat sleeping disorders such as narcolepsy and shift work disorder. Although it was used in treating sleeping conditions, the medication does not cure the sleeping disorders and is not recommended for use for people who are not getting enough sleep or as a treatment to ward off sleep.